Literature DB >> 1914226

Serum soluble CD4 and CD8 levels in Kawasaki disease.

S Furukawa1, T Matsubara, K Tsuji, T Motohashi, K Okumura, K Yabuta.   

Abstract

The levels of soluble CD4 (sCD4) and sCD8 in serum correlate with the T cell subset activation and may be important in monitoring and characterizing disease processes during immunological diseases. We compared acute Kawasaki disease (KD) with anaphylactoid purpura (AP) and acute febrile viral infections, such as measles and infectious mononucleosis (IM), in terms of serum sCD4 and sCD8 levels. The levels of serum sCD4 and sCD8 were measured by a sandwich enzyme immunoassay. In addition, peripheral blood mononuclear cell subsets were analysed by single and two-colour flow-cytometric analyses in KD and IM patients. The levels of serum sCD4 and sCD8 were significantly elevated in patients during acute stages of KD, measles and IM, but not AP. Peripheral blood CD4+, CD8+ and also HLA-DR+ T cells count did not increase during the acute stage of KD; however, peripheral blood CD8+ and HLA-DR+ T cell counts were increased during the acute stage of IM. Our results suggest that there is a low level of activation of peripheral blood T cells during acute KD, or that infiltrated T cells in some local tissues of KD patients contribute to the elevated levels of serum sCD4 and sCD8.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1914226      PMCID: PMC1554161          DOI: 10.1111/j.1365-2249.1991.tb05785.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  HIV infection is blocked in vitro by recombinant soluble CD4.

Authors:  R A Fisher; J M Bertonis; W Meier; V A Johnson; D S Costopoulos; T Liu; R Tizard; B D Walker; M S Hirsch; R T Schooley
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

2.  Soluble CD4 molecules neutralize human immunodeficiency virus type 1.

Authors:  A Traunecker; W Lüke; K Karjalainen
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

3.  A soluble CD4 protein selectively inhibits HIV replication and syncytium formation.

Authors:  R E Hussey; N E Richardson; M Kowalski; N R Brown; H C Chang; R F Siliciano; T Dorfman; B Walker; J Sodroski; E L Reinherz
Journal:  Nature       Date:  1988-01-07       Impact factor: 49.962

4.  A critical analysis of serum and urine interleukin-2 receptor assays in renal allograft recipients.

Authors:  R B Colvin; F I Preffer; T C Fuller; M C Brown; S H Ip; P C Kung; A B Cosimi
Journal:  Transplantation       Date:  1989-11       Impact factor: 4.939

5.  Comparison of Kawasaki disease and infectious mononucleosis in terms of natural killer cell and CD8+ T cell subsets.

Authors:  S Furukawa; T Matsubara; K Tsuji; T Motohashi; T Watanabe; Y Umezawa; K Yabuta
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

6.  The acute phase nature of interleukin 6: studies in Kawasaki disease and other febrile illnesses.

Authors:  Y Ueno; N Takano; H Kanegane; T Yokoi; A Yachie; T Miyawaki; N Taniguchi
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

7.  Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin.

Authors:  S Furukawa; T Matsubara; K Jujoh; K Sasai; S Nakachi; T Sugawara; K Yabuta; H Kato
Journal:  Eur J Pediatr       Date:  1990-11       Impact factor: 3.183

8.  Elevated soluble CD8 levels in sera of human immunodeficiency virus-infected populations.

Authors:  M M Reddy; M Lange; M H Grieco
Journal:  J Clin Microbiol       Date:  1989-02       Impact factor: 5.948

9.  Immune activation in measles.

Authors:  D E Griffin; B J Ward; E Jauregui; R T Johnson; A Vaisberg
Journal:  N Engl J Med       Date:  1989-06-22       Impact factor: 91.245

10.  Decreased production of CD8 (T8) antigen after immunotherapy.

Authors:  K H Hsieh
Journal:  J Clin Immunol       Date:  1989-03       Impact factor: 8.317

View more
  17 in total

Review 1.  Immunological profile of peripheral blood lymphocytes and monocytes/macrophages in Kawasaki disease.

Authors:  T Matsubara; T Ichiyama; S Furukawa
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

2.  Cytokines and soluble CD4 and CD8 molecules in rheumatoid arthritis: relationship to systematic vasculitis and microvascular capillaroscopic abnormalities.

Authors:  A Kuryliszyn-Moskal
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

3.  Bio-modulators in platelet-rich plasma: a comparison of the amounts in products from healthy donors and patients produced with three different techniques.

Authors:  Gianluca Ubezio; Massimo Ghio; Paola Contini; Roberta Bertorello; Gennaro Marino; Andrea Tomasini; Gino Tripodi
Journal:  Blood Transfus       Date:  2013-01-23       Impact factor: 3.443

4.  Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease.

Authors:  Haruyuki Makata; Takashi Ichiyama; Ryutaro Uchi; Tsuyoshi Takekawa; Tomoyo Matsubara; Susumu Furukawa
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-08-01       Impact factor: 3.000

5.  Soluble CD4 and CD8 molecules in patients with systemic sclerosis.

Authors:  Y Tokano; H Kaneko; T Obara; H Hashimoto; K Okumura; S Hirose
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

6.  Decreased interferon-gamma (IFN-gamma)-producing T cells in patients with acute Kawasaki disease.

Authors:  T Matsubara; K Katayama; T Matsuoka; M Fujiwara; M Koga; S Furukawa
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

7.  Soluble CD4 and CD8 in serum from patients with localized scleroderma.

Authors:  S Sato; M Fujimoto; K Kikuchi; H Ihn; K Tamaki; K Takehara
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

8.  Changes in levels of soluble T-cell activation markers, sIL-2R, sCD4 and sCD8, in relation to disease exacerbations in patients with systemic lupus erythematosus: a prospective study.

Authors:  P E Spronk; E J ter Borg; M G Huitema; P C Limburg; C G Kallenberg
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

9.  T cell activation profiles in Kawasaki syndrome.

Authors:  P A Brogan; V Shah; L A Clarke; M J Dillon; N Klein
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

10.  Mononuclear cell subsets and coronary artery lesions in Kawasaki disease.

Authors:  S Furukawa; T Matsubara; K Yabuta
Journal:  Arch Dis Child       Date:  1992-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.